NOVEMBER 2011
IDF 5K Walk/Run registration is now open!
World Diabetes Congress participants, diabetes advocates and sports enthusiasts can once again show their support by “Running for Diabetes” during the IDF 5K Run/Walk, which will take place on Thursday 8 December 2011 at Za’abeel Park. Aerobic warm-up is at 07:15 and the Run/Walk starts at 07:30.
The IDF 5K Run/Walk serves as a platform to raise awareness and promote the importance of increased physical activity which can help prevent diabetes and its complications.
There will be no restriction to the number of people participating in the run/walk. Participation is free for all registered delegates of the World Diabetes Congress and interested members of the public are most welcome. However, intending participants for the race must sign up here to be allowed to take part in the IDF 5K Run/Walk. For more information please contact info@tracs.net
CONGRESS INFORMATION
Passport and visa alert
Participants of the World Diabetes Congress are strongly reminded that they must be in possession of a valid passport which must have a minimum of two blank pages and must be valid for at least 6 months from the date of leaving the United Arab Emirates.
All participants of the World Diabetes Congress must also have a valid visa except nationals of the Gulf Co-operation Council States and other nationals mentioned here.
It is important that you thoroughly check your visa, passport and insurance requirements before your intended travel date.
IDF cannot be held responsible should such requirements not be fulfilled.
Hotel accommodation
3 weeks to go! Delegates are kindly reminded to book their accommodation as soon as possible.
Congress Solutions International (CSI), IDF’s official accommodation agent, will gladly assist you with your hotel reservations. Click here and secure your room at your earliest convenience.
Exhibition update
The World Diabetes Congress will feature an impressive exhibition with more than 70 exhibitors showcasing innovative ideas and products on the management and care of diabetes.
The Global Village – meet and network with the representatives of more than 160 IDF Member Associations from the different regions– Africa (AFR), Europe (EUR), Middle East and North Africa (MENA), North America & the Caribbean (NAC), South & Central America (SACA), South East Asia (SEA) and Western Pacific (WP).
Programme highlights
Abstracts now online
The International Diabetes Federation (IDF) is happy to announce the posting online of abstracts for the World Diabetes Congress 2011 in Dubai. The abstracts can be viewed in the online searchable programme. Reviewing abstracts before the congress will give you a better idea of what the presentation will be about and help you decide on which sessions will be of interest to you. Please visit our website and the online searchable programme by following this link to access these abstracts.
Satellite Symposia Programme
Information about the satellite symposia is accessible here
Continuous Medical Education (CME) credits
The World Diabetes Congress 2011 Dubai is accredited by the Faculty of Medicine & Health Sciences, UAE University, for a maximum of 27 hours of CME credits and by the
European Accreditation Council for Continuing Medical Education (EACCME) for 20 European external CME credits.
More programme highlights
(subject to change)
Late-breaking clinical trials
-
Format: Symposium
-
Stream: Clinical and Basic Science
-
8 December 2011, 08:30-10:30
|
|
Chair: Prof. Steven Kahn |
|
|
Chair: Prof. Hans-Henrik Parving |
|
08:30 |
The A1chieve study: Evaluation of insulin analogue therapy in 66,000 people from four continents |
|
|
Speaker: Prof. Philip Home |
|
09:00 |
New results from ADVANCE |
|
|
Speaker: Prof. John Chalmers |
|
09:30 |
Insulin Glargine and Cancer Risk: Latest data |
|
|
Speaker: Prof. Peter Boyle |
|
10:00 |
New results from ACCORD |
|
|
Speaker: Dr Lenore Launer |
Late-breaking abstracts session
-
Format: Oral Presentation
-
Stream: Clinical and Basic Science
-
8 December 2011, 10:45-12:45
|
|
Chair: Prof. John Chalmers |
|
|
Chair: Dr Lenore Launer |
|
10:45 |
Efficacy and safety of lixisenatide QD morning and evening injections vs placebo in T2DM inadequately controlled on metformin (GetGoal-M) |
|
|
Presenting Author: Dr Ronnie Aronson |
|
11:00 |
Active-controlled Dose-finding Study of Efficacy, Safety, and Tolerability of Multiple Doses of Ipragliflozin in Type 2 Diabetes Patients |
|
|
Presenting Author: Dr Vivian Fonseca |
|
11:30 |
Cardiovascular safety of sitagliptin versus a sulphonylurea in patients with type 2 diabetes mellitus: a pooled analysis |
|
|
Presenting Author: Dr Barry Goldstein |
|
11:15 |
Basal insulin glargine versus metformin treatment in drug naïve type 2 diabetes patients: results of the GLORY study |
|
|
Presenting Author: Dr Frank Pistrosch |
|
11:45 |
Long-term (up to 2 years) safety of lixisenatide once daily vs placebo in T2DM insufficiently controlled on metformin (GetGoal-F1) |
|
|
Presenting Author: Prof. Geremia Bolli |
|
12:00 |
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone - a factorial study |
|
|
Presenting Author: Prof. Robert Henry |
|
12:15 |
Efficacy and safety of early insulin glargine treatment in type 2 diabetes (T2D) patients poorly controlled with metformin |
|
|
Presenting Author: Prof. Markolf Hanefeld |
|
12:30 |
Effect of early multifactorial therapy on microvascular outcomes at 5 years in people with screen-detected T2DM: ADDITION-Europe trial |
|
|
Presenting Author: Prof. Annelli Sandbæk |
International Diabetes Epidemiology Group – IDEG
The International Diabetes Epidemiology Group, IDEG, cordially welcomes you to its 12th Symposium, which will be held at the University of Sharjah, United Arab Emirates, 2- 4 December 2011. The Symposium is an Official Academic Satellite Symposium of the World Diabetes Congress Dubai 2011, 4-8 December.
The event will be preceded by a one day IDEG Training Programme, on 1 December 2011. Please register your interest at ideg@bakeridi.edu.au
Association spotlight
Qatar Diabetes Association is pleased to participate in the upcoming IDF Congress 2011 and also proud that Dubai has been selected as the congress venue. This is the first World Diabetes Congress to be organized in the Middle East and North Africa Region (MENA), it is a perfect opportunity to exchange information especially across the region.
The congress comes at a critical time, due to the fact that diabetes currently affects more than 366 million people worldwide and is expected to affect 552 million by 2025.
The variety of session types will provide the delegates with the latest scientific information, leading to an exchange of best practices related to diabetes care, prevention and education.
It is also expected that the World Diabetes Congress 2011 will influence policy makers and local health authorities to create national diabetes plans and to make diabetes a health priority. We also hope the Congress will facilitate the implementation and monitoring of evidence-based policy and planning emerging from the UN NCD Summit.
On World Diabetes Day, November 14th, QDA will be planning a lot of activities. The Aspire Tower and Museum of Islamic Art on 14th November will be lit in blue. We are also hosting a diabetes walk on 18th November, where we expect more than 6000 participants.. A diabetes friendly healthy eating Programme will be available at the Sheraton Hotel and Millennium for a week starting from 14th Nov – 21st Nov, as well as healthy menu on Qatar Airways, Diabetes Chat on TV & radio and diabetes articles in leading Arabic & English newspapers.
I look forward to meeting many new colleagues in Dubai. We believe that our participation in the World Diabetes Congress will be an interesting and positive experience.
Good luck and best wishes.
Abdulla Al-Hamaq MPH, PhD, FRSPH
Executive Director
Qatar Diabetes Association – Qatar Foundation
Regional Manager / IDF MENA Region
We look forward to seeing you in Dubai!
Celina Renner on behalf of the IDF congress team
You are one of more than 16.000 people reading this newsletter. Please send it to anyone you think would benefit from the information.
Back to top
|
